Proactive Investors Australia

November 14, 2019

Cellmid is a well funded life sciences company that see a path to profitability

November 14, 2019

Cellmid appoints new Lyramid CEO to drive clinical development of midkine assets

November 14, 2019

Cellmid MD and CEO demonstrates confidence through further on-market share purchase

November 14, 2019

Cellmid’s Japanese shopping channel sale sets revenue record of $1.14 million

November 14, 2019

Cellmid Limited outlines key components for FY2020 growth strategy

November 14, 2019

Dave Gentry, host of “The RedChip Money Report”, interviews CEO Maria Halasz

November 14, 2019

Cellmid expanding products, portfolio and markets; and approaching profitability (YouTube)

November 14, 2019

Cellmid is a well funded life sciences company that see a path to profitability (YouTube)

November 14, 2019

Cellmid Limited outlines key components for FY2020 growth strategy (YouTube)